US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
174
Recruiting Now
174
← Back to US Map
Top Conditions in Indiana
Breast Cancer (4)Non-Small Cell Lung Cancer (3)Prostate Cancer (3)Head and Neck Squamous Cell Carcinoma (2)Pancreatic Cancer (2)Triple Negative Breast Cancer (2)Sickle Cell Disease (2)Ovarian Cancer (2)Endometrial Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Primary Immune Deficiency Disorder (2)Respiratory Distress Syndrome (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 174 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 174. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT07356843 N/A
Recruiting
Palliative Care for People With HF
Condition
Congestive Heart Failure
Enrollment
20 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT05005403 Phase 1
Recruiting
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With N...
Condition
Non-Small Cell Lung Cancer
Enrollment
694 pts
Location
United States, Canada, Israel
Sponsor
AbbVie
View Trial →
NCT06642610 N/A
Recruiting
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
Condition
Prediabetes
Enrollment
70 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT05009992 Phase 2
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Condition
Diffuse Intrinsic Pontine Glioma
Enrollment
360 pts
Location
United States, Australia, Israel
Sponsor
University of California, San
View Trial →
NCT05646316 Phase 3
Recruiting
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb D...
Condition
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Enrollment
428 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT06271265 Phase 1
Recruiting
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative A...
Condition
Postoperative Pain
Enrollment
48 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
View Trial →
NCT06237452 Phase 3
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Condition
Clostridium Difficile
Enrollment
852 pts
Location
United States, Australia, Belgium
Sponsor
Vedanta Biosciences, Inc.
View Trial →
NCT06975865 Phase 3
Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years Wit...
Condition
Sickle Cell Disease
Enrollment
192 pts
Location
United States, Belgium, Brazil
Sponsor
Sanofi
View Trial →
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
View Trial →
NCT06949410 Phase 1
Recruiting
HER2 Vaccine for Locally Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
36 pts
Location
United States
Sponsor
Pravin T.P Kaumaya
View Trial →
NCT05346796 N/A
Recruiting
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Condition
Cancer
Enrollment
250 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT05636176 Phase 3
Recruiting
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People...
Condition
Heart Failure
Enrollment
5,600 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
View Trial →
NCT04657068 Phase 1, Phase 2
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Condition
Advanced Cancer
Enrollment
442 pts
Location
United States, France, Spain
Sponsor
Artios Pharma Ltd
View Trial →
NCT07392255 Phase 1, Phase 2
Recruiting
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx00...
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
75 pts
Location
United States
Sponsor
Complement Therapeutics
View Trial →
NCT07448038 Phase 2
Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokin...
Condition
Atherosclerosis
Enrollment
162 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT03266640 Phase 2
Recruiting
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CM...
Condition
Cytomegalovirus Infections
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT02397668 N/A
Recruiting
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Condition
Tricuspid Valve Disease
Enrollment
78 pts
Location
United States
Sponsor
Corvivo Cardiovascular, Inc.
View Trial →
NCT06616844 N/A
Recruiting
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standar...
Condition
Wound Heal
Enrollment
194 pts
Location
United States
Sponsor
ConvaTec Inc.
View Trial →
NCT06481904 N/A
Recruiting
Registry for Stage 2 Type 1 Diabetes
Condition
Type 1 Diabetes
Enrollment
200 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT05468034 N/A
Recruiting
Exercise in Metastatic Breast Cancer: EMBody
Condition
Breast Cancer
Enrollment
100 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT07570121 Phase 1
Recruiting
Pharmacokinetics and Placental Transfer of Caffeine
Condition
Preterm Labor With Preterm Delivery
Enrollment
30 pts
Location
United States
Sponsor
Indiana University
View Trial →
Page 1 of 7 — 174 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology